Intellia Therapeutics Inc.
NTLA | NASDAQ
$12.66
+$0.44 (+3.60%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -202.87M | -96.23M | -202.11M | -101.32M | -101.26M | -114.33M | -128.9M | -135.71M | -146.98M | -107.44M | -132.16M | -122.22M | -123.68M | -103.13M | -113.41M | -113.23M | -100.68M | -146.87M | -81.24M | -71.64M | -68.81M | -46.21M |
Depreciation & Amortization | 4.28M | 2.2M | 377K | 4.94M | 2.47M | 2.5M | 2.57M | 2.61M | 2.6M | 2.51M | 2.47M | 2.29M | 2.17M | 2.05M | 2.03M | 1.95M | 1.84M | 1.75M | 1.88M | 1.79M | 1.63M | 1.59M |
Stock-Based Compensation | 31.55M | 13.48M | 90.79M | 19.6M | 22.04M | 21.84M | 39.62M | 39.62M | 40.86M | 34.18M | 35.04M | 35.35M | 36.4M | 27.26M | 24.63M | 25.22M | 23.07M | 18.49M | 14.56M | 15.41M | 10.61M | 6.42M |
Other Working Capital | -26.65M | -36.08M | -8.05M | 647K | -16.46M | -54.93M | 267K | 12.02M | 178K | -35.33M | 29.13M | -8.79M | -9.94M | -36.93M | -14.42M | -2.85M | -12.54M | -17.74M | 390K | -12.91M | 4.65M | -15.66M |
Other Non-Cash Items | -421K | 369K | 41.16M | -4.52M | -3.01M | -155K | -520K | -1.29M | 15.71M | -20.19M | -1.51M | 968K | -237K | 1.39M | 10.3M | 13.18M | 7.93M | 64.39M | 6.9M | 2.1M | 1.66M | 1.21M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -33.01M | -37.17M | 494K | 4.41M | -19.87M | -58.78M | 2.04M | 9.94M | 29.62M | -29.73M | 3.11M | -13.69M | -4.98M | -36.9M | -13.42M | -5.64M | -17.24M | -17.57M | 3.25M | -12.68M | 1.92M | -15.4M |
Operating Cash Flow | -200.46M | -117.35M | -69.29M | -76.9M | -99.62M | -148.93M | -85.2M | -84.84M | -58.19M | -120.66M | -93.05M | -101.38M | -90.32M | -109.33M | -89.87M | -78.53M | -85.09M | -79.8M | -54.65M | -65.02M | -52.98M | -52.38M |
Capital Expenditures | -1.89M | -79K | -126K | -29K | -239K | -735K | -981K | -1.28M | -1.01M | -2.51M | -1.52M | -4.33M | -4.3M | -3.83M | -3.91M | -4.24M | -3.98M | -46.26M | -2.87M | -4.54M | -2.94M | -2.41M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.83M | n/a | 118.42M | 56.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -267.36M | -46.97M | -680.11M | -116.65M | -55.6M | -83.21M | -169.1M | -206.1M | -300.81M | -259.56M | -149.78M | -129.37M | -243.29M | -382.03M | -236.43M | -161.07M | -31.52M | n/a | -250.86M | -587.33M | -37.1M | -148.33M |
Sales Maturities Of Investments | 193.89M | 113.35M | 588.99M | 115.94M | 162.75M | 178.27M | 321.65M | 178.71M | 277.63M | 267.97M | 197.23M | 213.2M | 213.05M | 263.62M | 210.19M | 212.8M | 130.85M | 93.73M | 94.61M | 192.49M | 73.3M | 125.2M |
Other Investing Acitivies | 90K | n/a | 123.43M | n/a | n/a | n/a | n/a | 20.97M | n/a | n/a | n/a | 83.83M | n/a | -118.42M | -56.24M | 150K | n/a | -44.83M | n/a | n/a | n/a | n/a |
Investing Cash Flow | -75.26M | 66.31M | 27.53M | -741K | 106.91M | 94.33M | 151.57M | -7.71M | -24.19M | 5.9M | 45.94M | 79.5M | -34.54M | -122.25M | -30.15M | 47.64M | 95.35M | 47.47M | -159.12M | -399.38M | 33.26M | -25.54M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 97K | 1.24M | n/a | 2.35M | 1.7M | 2.85M | 1.96M | 2.87M | 4.38M | n/a | 755K | 2.11M | 722K | n/a | 8.44M | n/a | 20.37M | n/a | 13.34M |
Financial Cash Flow | 229.69M | 33.57M | 1.98M | 114.86M | 14.65M | n/a | 2.32M | 82.19M | 41.25M | 59.99M | 106.48M | 19.1M | 2.52M | 2.22M | 505.76M | 23.98M | 5.9M | 47.32M | 2.28M | 668.68M | 7.13M | 58.6M |
Net Cash Flow | -46.04M | -20.77M | -37.93M | 37.22M | 21.94M | -54.6M | 68.69M | -10.35M | -41.13M | -54.77M | 59.37M | -2.78M | -122.34M | -229.36M | 385.74M | -6.91M | 16.15M | 14.99M | -213.23M | 204.28M | -12.59M | -19.32M |
Free Cash Flow | -202.35M | -117.43M | -69.41M | -76.93M | -99.86M | -149.67M | -86.18M | -86.12M | -59.2M | -123.17M | -94.57M | -105.71M | -94.62M | -113.16M | -93.78M | -82.76M | -89.07M | -126.06M | -57.52M | -69.56M | -55.92M | -54.79M |
Adj. Free Cash Flow | -233.9M | -130.9M | -160.2M | -96.53M | -121.9M | -171.51M | -125.79M | -125.74M | -100.06M | -157.34M | -129.62M | -141.07M | -131.02M | -140.42M | -118.41M | -107.98M | -112.14M | -144.55M | -72.08M | -84.97M | -66.53M | -61.21M |
Maintenance CapEx | -1.89M | -79K | n/a | n/a | n/a | -735K | n/a | -1.28M | -1.01M | n/a | -1.52M | -4.33M | -4.3M | -1.24M | -2.81M | n/a | n/a | -38.92M | n/a | -4.54M | -2.94M | -2.41M |
Growth CapEx | n/a | n/a | -126K | -29K | -239K | n/a | -981K | n/a | n/a | -2.51M | n/a | n/a | n/a | -2.59M | -1.1M | -4.24M | -3.98M | -7.35M | -2.87M | n/a | n/a | n/a |
Owner Earnings | -202.35M | -117.43M | -69.29M | -76.9M | -99.62M | -149.67M | -85.2M | -86.12M | -59.2M | -120.66M | -94.57M | -105.71M | -94.62M | -110.57M | -92.68M | -78.53M | -85.09M | -118.72M | -54.65M | -69.56M | -55.92M | -54.79M |
Add to Watchlist
Select watchlists to add or remove NTLA